Fake Malaria Drugs in the World

Third of malaria drugs are used around the world to stem the disease proved to be false.

The findings are revealed in The Lancet Infectious Diseases study that examines approximately 1,500 samples from seven malaria drugs from seven countries in Southeast Asia.

They claimed the drugs malaria is qualified very low and false, causing drug resistance and treatment failure.

In addition to Southeast Asia, experts from research institutes also found similar data in 21 countries of sub-Saharan Africa after testing more than 2,500 drug samples.

A number of observers to assess health problems these findings represent a'' warning''.

The researchers from the Fogarty International Center at the Institute of Health (NIH) who participated in this study believe that this problem may be much larger than the data revealed.

"Most cases probably go unreported, reported to the wrong institution, or remain anonymous by drug companies,'' said the researcher.

Minimal supervision

After all the research related to drug quality has never been done extensively in China or India - a country with one third of world population and'' likely'' source of many counterfeit drugs, including anti-malaria drugs.

Nayyar Gaurvika lead researcher emphasized that the 3.3 billion people at risk of malaria, which has been classified as endemic in 106 countries.

"Between 655 000 and 1.2 million people die each year from Plasmodium falciparum infection,'' he said.

'' Most of this morbidity and mortality can be avoided if the drug available to patients nutritious, high quality, and used properly.''

This study also found that many facilities are not adequate to monitor the quality of anti-malaria drugs and low knowledge of consumers and health professionals over medication therapy.

And also found a lack of regulation that oversees the drug manufacturer and the lack of penalties for counterfeiters.

However, the malaria mortality rate has dropped more than 25% globally since 2000, and by 33% in the African region.

But the UN health organization, WHO said that maintaining the current rate of progress will not be sufficient to meet the target of malaria control globally.

This requires investment in the renewal of diagnostic testing, treatment, and surveillance for malaria.